What Happened
A patient has reported experiencing persistent numbness four years after undergoing treatment as part of a clinical trial for multiple myeloma. The individual shared their ongoing experience with this condition following their participation in the experimental therapy.
The article does not specify the exact nature of the numbness, its severity, or whether it is localized to a particular area of the body. It also does not detail the type of injections used in the clinical trial or the expected outcomes of the treatment.
Further information regarding the patient's current medical status, the specific goals of the clinical trial, or any potential treatments for the persistent numbness is not available in the provided text.
Key Facts
- 1
A patient reports persistent numbness.
- 2
The numbness has persisted for four years.
- 3
The patient participated in a clinical trial for multiple myeloma.
- 4
The numbness began after the clinical trial injections.